Skip to content

Follow-up With Preimplantation Genetic Testing Patients

Follow-up With Preimplantation Genetic Testing Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04477863
Enrollment
10000
Registered
2020-07-20
Start date
2020-07-11
Completion date
2050-12-31
Last updated
2025-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Genetic Disease, IVF

Keywords

PGT, Follow-up

Brief summary

The main purpose of this study is to perform longitudinal evaluations of clinical outcomes and personal perspectives following utilization of preimplantation genetic testing (PGT). Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. A licensed genetic counselor will conduct a recorded interview.

Detailed description

Purpose: To perform longitudinal studies of clinical outcomes and personal perspectives following utilization of PGT. Background: Preimplantation Genetic Testing (PGT) is a commercially available adjunct to in vitro fertilization (IVF) and is now performed in over 40% of treatment cycles in the United Sates (Society for Assisted Reproductive Technology Annual Report, 2018). Several clinical genetics entities offer PGT services, including Genomic Prediction Clinical Laboratory (CLIA# 31D2152380, CAP# 8488628). It is common practice to perform interviews with, and record reviews of patients following clinical interventions. Results may provide instrumental information for the scientific and medical community to improve clinical care. We would like to review medical records in order to recruit patients to participate in longitudinal studies of clinical outcomes and personal perspectives following utilization of PGT. Study Design and Methods: Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. Patients who opted out of participating in research during informed consent to perform PGT will be ineligible for inclusion. Clinical PGT consent forms will be reviewed to identify patients that indicated willingness to participate in research. Eligible patients will be counseled on the study and consented for participation by a licensed genetic counselor. A total of 10,000 patients will be recruited. Following patient recruitment and informed consent, patient records and results of patient interviews may be used for publication in peer-reviewed scientific journals, presentation at scientific conferences or company meetings. As it is in standard practice, all external communication of results will maintain de-identification of all protected health information of all subjects (HIPAA guidelines). A licensed genetic counselor will conduct a recorded interview. Patient PGT, family history, and ethnicity data and information may be included in cohort analyses.

Interventions

Non Applicable

Sponsors

Genomic Prediction Inc.
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Patients indicating willingness to participate in research during informed consent to perform PGT

Exclusion criteria

* Patients who opted out of participating in research during informed consent to perform PGT

Design outcomes

Primary

MeasureTime frameDescription
Patient perspectives on PGT2 yearsAnalysis of interview responses

Countries

United States

Contacts

Primary ContactTalia Metzgar, RN
Talia@genomicprediction.com(973) 529-4223
Backup ContactBhavini Rana
bhavini@genomicprediction.com(973) 529-4223

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026